Corruption and the Effectiveness of Imported Antiretroviral Drugs in Averting HIV Deaths

Posted: 18 Apr 2013 Last revised: 9 Jul 2013

See all articles by Willa Friedman

Willa Friedman

University of Houston - Department of Economics

Date Written: April 18, 2013

Abstract

This paper looks at the impact of corruption on the effectiveness of antiretroviral drugs in preventing deaths due to HIV and the potential channels that generate this relationship. This is based on a unique panel dataset of countries in sub-Saharan Africa, which combines information on all imported antiretroviral drugs from the World Health Organization’s Global Price Reporting Mechanism with measures of corruption and estimates of the HIV prevalence and the number of deaths in each year and in each country. Countries with higher levels of corruption experience a significantly smaller drop in HIV deaths as a result of the same quantity of ARVs imported. This is followed up with a single case-study from Kenya to illustrate one potential mechanism for the observed effect, demonstrating that disproportionately more clinics begin distributing ARVs in areas that are predominantly represented by the new leader’s ethnic group.

Suggested Citation

Friedman, Willa, Corruption and the Effectiveness of Imported Antiretroviral Drugs in Averting HIV Deaths (April 18, 2013). Available at SSRN: https://ssrn.com/abstract=2253688

Willa Friedman (Contact Author)

University of Houston - Department of Economics ( email )

Houston, TX 77204-5882
United States

Do you have a job opening that you would like to promote on SSRN?

Paper statistics

Abstract Views
335
PlumX Metrics